• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维甲酸诱导基因1与史密斯-马吉尼斯综合征:从遗传学到生物学及可能的治疗策略

Retinoic Acid Induced 1 and Smith-Magenis Syndrome: From Genetics to Biology and Possible Therapeutic Strategies.

作者信息

Covarelli Jasmine, Vinciarelli Elisa, Mirarchi Alessandra, Prontera Paolo, Arcuri Cataldo

机构信息

Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy.

Medical Genetics and Rare Disease Unit, Maternal-Infantile Department, S. Maria della Misericordia Hospital, 06132 Perugia, Italy.

出版信息

Int J Mol Sci. 2025 Jul 11;26(14):6667. doi: 10.3390/ijms26146667.

DOI:10.3390/ijms26146667
PMID:40724914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296005/
Abstract

Haploinsufficiency disorders are genetic diseases caused by reduced gene expression, leading to developmental, metabolic, and tumorigenic abnormalities. The dosage-sensitive Retinoic Acid Induced 1 () gene, located within the 17p11.2 region, is central to the core features of Smith--Magenis syndrome (SMS) and Potocki--Lupski syndrome (PTLS), caused by the reciprocal microdeletions and microduplications of this region, respectively. SMS and PTLS present contrasting phenotypes. SMS is characterized by severe neurobehavioral manifestations, sleep disturbances, and metabolic abnormalities, and PTLS shows milder features. Here, we detail the molecular functions of in its wild-type and haploinsufficiency conditions (RAI1+/-), as studied in animal and cellular models. RAI1 acts as a transcription factor critical for neurodevelopment and synaptic plasticity, a chromatin remodeler within the Histone 3 Lysine 4 (H3K4) writer complex, and a regulator of faulty 5'-capped pre-mRNA degradation. Alterations of RAI1 functions lead to synaptic scaling and transcriptional dysregulation in neural networks. This review highlights key molecular mechanisms of RAI1, elucidating its role in the interplay between genetics and phenotypic features and summarizes innovative therapeutic approaches for SMS. These data provide a foundation for potential therapeutic strategies targeting RAI1, its mRNA products, or downstream pathways.

摘要

单倍剂量不足疾病是由基因表达减少引起的遗传性疾病,会导致发育、代谢和致瘤异常。位于17p11.2区域的剂量敏感视黄酸诱导1(RAI1)基因,分别是由该区域的相互微缺失和微重复引起的史密斯-马吉尼斯综合征(SMS)和波托基-卢斯基综合征(PTLS)核心特征的关键所在。SMS和PTLS呈现出截然不同的表型。SMS的特征是严重的神经行为表现、睡眠障碍和代谢异常,而PTLS的特征则较为轻微。在此,我们详细阐述了在动物和细胞模型中所研究的RAI1在其野生型和单倍剂量不足状态(RAI1+/-)下的分子功能。RAI1作为一种对神经发育和突触可塑性至关重要的转录因子,是组蛋白3赖氨酸4(H3K4)书写复合物中的染色质重塑因子,也是有缺陷的5'-帽状前体mRNA降解的调节因子。RAI1功能的改变会导致神经网络中的突触缩放和转录失调。本综述强调了RAI1的关键分子机制,阐明了其在遗传学与表型特征相互作用中的作用,并总结了针对SMS的创新治疗方法。这些数据为针对RAI1及其mRNA产物或下游途径的潜在治疗策略奠定了基础。

相似文献

1
Retinoic Acid Induced 1 and Smith-Magenis Syndrome: From Genetics to Biology and Possible Therapeutic Strategies.维甲酸诱导基因1与史密斯-马吉尼斯综合征:从遗传学到生物学及可能的治疗策略
Int J Mol Sci. 2025 Jul 11;26(14):6667. doi: 10.3390/ijms26146667.
2
Retinoic Acid-Induced 1 Gene and Neuropsychiatric Diseases: A Systematic Review.维甲酸诱导基因1与神经精神疾病:一项系统综述
Expert Rev Mol Med. 2025 May 29;27:e17. doi: 10.1017/erm.2025.12.
3
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation.从一名患有杂合性RAI1突变的史密斯-马吉尼斯综合征患者中生成并鉴定CSSi021-A(15665)人诱导多能干细胞系。
Stem Cell Res. 2025 Aug;86:103726. doi: 10.1016/j.scr.2025.103726. Epub 2025 Apr 26.
4
Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways.史密斯-马根尼斯综合征:RAI1 基因杂合缺失导致神经和代谢途径中基因调控改变。
Expert Rev Mol Med. 2011 Apr 19;13:e14. doi: 10.1017/S1462399411001827.
5
Potocki-Lupski Syndrome波托基-卢普斯基综合征
6
Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.对疑似 Smith-Magenis 综合征且无 17p11.2 缺失患者的视黄酸诱导基因 1(RAI1)进行分子分析。
PLoS One. 2011;6(8):e22861. doi: 10.1371/journal.pone.0022861. Epub 2011 Aug 8.
7
Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 (RAI1) in human brain.人类大脑中剂量敏感基因视黄酸诱导-1(RAI1)mRNA表达的遗传调控证据。
Sci Rep. 2016 Jan 8;6:19010. doi: 10.1038/srep19010.
8
Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.Smith-Magenis 综合征小鼠模型中的昼夜节律异常:RAI1 参与的证据。
Am J Med Genet A. 2013 Jul;161A(7):1561-8. doi: 10.1002/ajmg.a.35941. Epub 2013 May 23.
9
Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.17p11.2-11.2 相互缺失和重复:韩国史密斯-马根尼斯综合征和波托基-卢普斯基综合征患者。
J Korean Med Sci. 2012 Dec;27(12):1586-90. doi: 10.3346/jkms.2012.27.12.1586. Epub 2012 Dec 7.
10
Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.史密斯-马根尼斯综合征导致时钟基因转录的中断,并揭示了 RAI1 在维持昼夜节律中的重要作用。
Am J Hum Genet. 2012 Jun 8;90(6):941-9. doi: 10.1016/j.ajhg.2012.04.013. Epub 2012 May 10.

本文引用的文献

1
SINEUP RNA rescues molecular phenotypes associated with CHD8 suppression in autism spectrum disorder model systems.SINEUP RNA可挽救自闭症谱系障碍模型系统中与CHD8抑制相关的分子表型。
Mol Ther. 2025 Mar 5;33(3):1180-1196. doi: 10.1016/j.ymthe.2024.12.043. Epub 2024 Dec 30.
2
Structural basis of eukaryotic transcription termination by the Rat1 exonuclease complex.真核生物转录终止的 Rat1 核酸外切酶复合物的结构基础。
Nat Commun. 2024 Sep 8;15(1):7854. doi: 10.1038/s41467-024-52157-0.
3
Ataxin-2: a powerful RNA-binding protein.ataxin-2:一种强大的RNA结合蛋白。
Discov Oncol. 2024 Jul 22;15(1):298. doi: 10.1007/s12672-024-01158-y.
4
Family case of Potocki-Lupski syndrome.波托基-卢普斯基综合征家族病例。
Mol Cytogenet. 2024 Mar 22;17(1):6. doi: 10.1186/s13039-024-00673-5.
5
Smith-Magenis syndrome protein RAI1 regulates body weight homeostasis through hypothalamic BDNF-producing neurons and neurotrophin downstream signalling.Smith-Magenis 综合征蛋白 RAI1 通过下丘脑产生 BDNF 的神经元和神经营养因子下游信号调节体重稳态。
Elife. 2023 Nov 13;12:RP90333. doi: 10.7554/eLife.90333.
6
A case of Smith-Magenis syndrome with skin manifestations caused by a novel locus mutation in the RAI1 gene.一例因 RAI1 基因新位点突变引起皮肤表现的 Smith-Magenis 综合征。
J Int Med Res. 2023 Sep;51(9):3000605231190553. doi: 10.1177/03000605231190553.
7
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.CRISPR-Cas 介导的转录调控:CRISPRa 和 CRISPRi 的治疗潜力。
Mol Ther. 2023 Jul 5;31(7):1920-1937. doi: 10.1016/j.ymthe.2023.03.024. Epub 2023 Mar 24.
8
Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here?《表观遗传学和染色质临床 5 年经验:我们学到了什么,以及未来的方向?》
Hum Genet. 2024 Apr;143(4):607-624. doi: 10.1007/s00439-023-02537-1. Epub 2023 Mar 23.
9
A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.诊断史密斯-马根尼斯综合征患者存在伯特-霍格-杜布综合征:癌症筛查建议。
Am J Med Genet A. 2023 Feb;191(2):490-497. doi: 10.1002/ajmg.a.63049. Epub 2022 Dec 13.
10
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome.视黄酸诱导的 1 号基因单倍剂量不足改变脂质代谢,导致 Smith-Magenis 综合征发生自噬缺陷。
Cell Death Dis. 2022 Nov 21;13(11):981. doi: 10.1038/s41419-022-05410-7.